According to Onconova Therapeutics's latest financial reports the company's current earnings are S$0.22 Million. In 2023 the company made an earning of -S$25.31 Million, an increase over its 2022 earnings that were of -S$25.33 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$24.49 Million | -3.24% |
2023 | -S$25.31 Million | -0.08% |
2022 | -S$25.33 Million | 17.33% |
2021 | -S$21.59 Million | -35.74% |
2020 | -S$33.6 Million | 17.03% |
2019 | -S$28.71 Million | 4.67% |
2018 | -S$27.43 Million | -14.73% |
2017 | -S$32.17 Million | 22.53% |
2016 | -S$26.25 Million | -18.14% |
2015 | -S$32.07 Million | -62.36% |
2014 | -S$85.18 Million | 2.66% |
2013 | -S$82.97 Million | 107.68% |
2012 | -S$39.96 Million |